Live Oak Private Wealth LLC Raises Position in Agilent Technologies, Inc. (NYSE:A)

Live Oak Private Wealth LLC raised its stake in shares of Agilent Technologies, Inc. (NYSE:A - Free Report) by 8.1% during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 48,792 shares of the medical research company's stock after purchasing an additional 3,663 shares during the period. Live Oak Private Wealth LLC's holdings in Agilent Technologies were worth $5,708,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Flynn Zito Capital Management LLC grew its stake in shares of Agilent Technologies by 3.8% during the fourth quarter. Flynn Zito Capital Management LLC now owns 1,871 shares of the medical research company's stock valued at $251,000 after buying an additional 69 shares during the last quarter. IFP Advisors Inc grew its stake in shares of Agilent Technologies by 17.7% during the fourth quarter. IFP Advisors Inc now owns 458 shares of the medical research company's stock valued at $62,000 after buying an additional 69 shares during the last quarter. Tiemann Investment Advisors LLC grew its stake in shares of Agilent Technologies by 5.6% during the fourth quarter. Tiemann Investment Advisors LLC now owns 1,423 shares of the medical research company's stock valued at $191,000 after buying an additional 75 shares during the last quarter. Rothschild Investment LLC grew its stake in shares of Agilent Technologies by 19.2% during the fourth quarter. Rothschild Investment LLC now owns 491 shares of the medical research company's stock valued at $66,000 after buying an additional 79 shares during the last quarter. Finally, CIBC Private Wealth Group LLC grew its stake in shares of Agilent Technologies by 1.2% during the fourth quarter. CIBC Private Wealth Group LLC now owns 7,479 shares of the medical research company's stock valued at $1,025,000 after buying an additional 87 shares during the last quarter.

Agilent Technologies Trading Up 0.1%

A opened at $115.61 on Monday. The stock's fifty day moving average is $110.67 and its two-hundred day moving average is $124.50. The company has a market capitalization of $32.84 billion, a P/E ratio of 28.55, a PEG ratio of 3.51 and a beta of 1.23. Agilent Technologies, Inc. has a 52 week low of $96.43 and a 52 week high of $153.84. The company has a quick ratio of 1.60, a current ratio of 2.09 and a debt-to-equity ratio of 0.55.

Agilent Technologies (NYSE:A - Get Free Report) last announced its quarterly earnings results on Wednesday, May 28th. The medical research company reported $1.31 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.26 by $0.05. Agilent Technologies had a return on equity of 25.92% and a net margin of 17.59%. The business had revenue of $1.67 billion for the quarter, compared to the consensus estimate of $1.63 billion. During the same period last year, the business posted $1.22 EPS. The business's revenue was up 6.0% compared to the same quarter last year. Analysts forecast that Agilent Technologies, Inc. will post 5.58 earnings per share for the current year.

Agilent Technologies Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, July 23rd. Stockholders of record on Tuesday, July 1st will be issued a $0.248 dividend. The ex-dividend date of this dividend is Tuesday, July 1st. This represents a $0.99 dividend on an annualized basis and a dividend yield of 0.86%. Agilent Technologies's dividend payout ratio is presently 24.44%.

Analyst Upgrades and Downgrades

A number of research firms have recently commented on A. Wells Fargo & Company cut their target price on Agilent Technologies from $155.00 to $135.00 and set an "overweight" rating on the stock in a research note on Thursday, April 17th. UBS Group cut their target price on Agilent Technologies from $150.00 to $130.00 and set a "neutral" rating on the stock in a research note on Thursday, May 29th. JPMorgan Chase & Co. cut their target price on Agilent Technologies from $160.00 to $155.00 and set an "overweight" rating on the stock in a research note on Thursday, May 29th. Wall Street Zen cut Agilent Technologies from a "buy" rating to a "hold" rating in a research note on Saturday, June 14th. Finally, TD Cowen upped their target price on Agilent Technologies to $150.00 and gave the company a "buy" rating in a research note on Thursday, May 29th. Eight research analysts have rated the stock with a hold rating and seven have given a buy rating to the company. According to data from MarketBeat, the company presently has a consensus rating of "Hold" and a consensus target price of $140.15.

Insider Activity

In other news, Director Daniel K. Podolsky sold 1,819 shares of Agilent Technologies stock in a transaction on Monday, March 31st. The stock was sold at an average price of $116.46, for a total value of $211,840.74. Following the transaction, the director now directly owns 35,737 shares in the company, valued at approximately $4,161,931.02. This trade represents a 4.84% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.

Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:A - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.